European Alzheimer's Disease (AD) Therapeutics Markets

Table of Contents

1. Executive Summary

• 1. Summary of the European Alzheimer' s Disease (AD) Therapeutics Market
  • 1. Key Features of the European Alzheimer' s Disease (AD) Therapeutics Market

2. Glossary of Terms

• 1. List of Terms
  • 1. Abbreviations for the European AD Therapeutics Market

3. Market Engineering Research Methodology

• 1. Description of Research Methodology
  • 1. Research Methodology for the European AD Therapeutics Market

4. Industry Challenges

• 1. Challenges and Issues
  • 1. Main Challenges Facing the European AD Therapeutics Market

5. Market Engineering Research of the European Alzheimer' s Disease Therapeutics Market

• 1. Forecasts of the Overall Market
  • 1. Introduction
  • 2. Disease Burden
  • 3. Prevalence and Incidence
  • 4. Pharmacological Treatment Options
  • 5. Market Engineering Measurements
  • 6. Market Drivers
    • a. Ageing Population Demographics
    • b. High Level of Unmet Clinical Needs
    • c. Memantine Fuelling Overall Market Growth
    • d. Increasing Promotional Efforts
  • 7. Market Restraints
    • a. Low Level of Reimbursement for AD Therapeutics
    • b. Negative Implications of Reference Pricing
    • c. High Degree of Risk Associated with AD R&D
    • d. Lack of Strong Clinical Guidelines Regarding the Expanded Usage of AD Therapeutics
  • 8. Revenue Forecasts
  • 9. Geographic Trends
  • 10. Segment-wise Trends
  • 11. Competitive Structure
  • 12. Market Share Analysis

6. Segment-wise Trends

• 1. Acetyl Cholinesterase (AChEI) Inhibitors
  • 1. Market Overview
  • 2. Market Engineering Measurements
• 2. N-methyl D-aspartate (NMDA) Receptor Antagonists
  • 1. Market Overview
  • 2. Market Engineering Measurements

7. Opportunities by Geographic Region

• 1. Opportunities in France
  • 1. Market Overview
  • 2. Market Engineering Measurements
  • 3. Pricing and Reimbursement
• 2. Opportunities in Germany
  • 1. Market Overview
  • 2. Market Engineering Measurements
  • 3. Pricing and Reimbursement
• 3. Opportunities in Spain
  • 1. Market Overview
  • 2. Market Engineering Measurements
  • 3. Pricing and Reimbursement
• 4. Opportunities in the United Kingdom
  • 1. Market Overview
  • 2. Market Engineering Measurements
  • 3. Pricing and Reimbursement
• 5. Opportunities in Italy
  • 1. Market Overview
  • 2. Market Engineering Measurements
  • 3. Pricing and Reimbursement

8. Brand Analysis

• 1. Analysis of leading Brands in the World AD Therapeutics Market
  • 1. Aricept
  • 2. Reminyl
  • 3. Exelon
  • 4. Ebixa

9. Global Research and Development Activities

• 1. Promising Research in AD Therapeutics
  • 1. Research and Development Area of Focus
  • 2. Acetyl Cholinesterase Inhibitors
  • 3. Estrogen Replacement Therapy/Hormone Replacement Therapy
  • 4. Nerve Growth Factors
  • 5. Other Approaches

10. Pipeline Insight

• 1. AD Therapeutics in Various Phases of Development
  • 1. Analysis by Phase of Development
• 2. AD Therapeutics by Company
  • 1. Astrazeneca
  • 2. Elan Corporation Plc
  • 3. Glaxosmithkline
  • 4. Merck & Co Inc.
  • 5. Myriad Genetics Inc.
  • 6. Neuropharma S.A.
  • 7. Novartis AG
  • 8. Sanofi-Aventis
  • 9. Wyeth

11. Strategic Recommendations

• 1. Strategies for the European AD Therapeutics Market
  • 1. Recommendations to Participants

12. Decision Support Databases

• 1. DSD Tables
  • 1. Prevalence of Dementia
  • 2. Prevalence of Alzheimer' s Disease
  • 3. Mortality of Alzheimer' s Disease
  • 4. Male Population above 65 Years
  • 5. Female Population above 65 Years
  • 6. Number of Beds in Psychiatric Hospitals
  • 7. Number of Physicians

List of Figures

Chapter 4

• AD Therapeutics Market: Impact of Top Industry Challenges (Europe), 2006-2012

Chapter 5

• Total AD Therapeutics Market: EURODEM Prevalence Rates for Men and Women in Nine Different Age Groups for Dementia (Europe), 1980-1990
• Total AD Therapeutics Market: Market Drivers Ranked in Order of Impact (Europe), 2006-2012
• Total AD Therapeutics Market: Market Restraints Ranked in Order of Impact (Europe), 2006-2012
• Total AD Therapeutics Market: Revenue Forecasts (Europe), 2002-2012
• Total AD Therapeutics Market: Per cent of Revenues by Geographic Region (Europe), 2005
• Total AD Therapeutics Market: Per cent of Revenues by Segment (Europe), 2005
• Total AD Therapeutics Market: Competitive Structure (Europe), 2005
• Total AD Therapeutics Market: Market Shares and Revenue Growth Rates of Leading Products (Europe), 2005

Chapter 8

• AD Therapeutics Market: Key Features of Aricept (World), 2005
• AD Therapeutics Market: Key Features of Reminyl (World), 2005
• AD Therapeutics Market: Key Features of Exelon (World), 2005
• AD Therapeutics Market: Key Features of Ebixa (World), 2005

Chapter 10

• AD Therapeutics Market: Number of Drugs in Various Stages of Development (World), 2005
• AD Therapeutics Market: Product Pipeline of Astrazeneca International (World), 2005
• AD Therapeutics Market: Product Pipeline of Elan Corporation Plc (World), 2005
• AD Therapeutics Market: Product Pipeline of Glaxosmithkline Inc., (World), 2005
• AD Therapeutics Market: Product Pipeline of Merck & Co., Inc. (World), 2005
• AD Therapeutics Market: Product Pipeline of Myriad Genetics, Inc. (World), 2005
• AD Therapeutics Market: Product Pipeline of Neuropharma, S.A., (World), 2005
• AD Therapeutics Market: Product Pipeline of Novartis AG (World), 2005
• AD Therapeutics Market: Product Pipeline of Sanofi-Aventis Group (World), 2005
• AD Therapeutics Market: Product Pipeline of Wyeth (World), 2005

Chapter 12

• Decision Support Database: Prevalence of Dementia in ' 000 (World), 1999-2006
• Decision Support Database: Prevalence of Alzheimer' s Disease in ' 000 (World), 1999-2006
• Decision Support Database: Mortality Due to Alzheimer (World), 1999-2006
• Decision Support Database: Total Male Population of Age 65 Years and Above in Millions (World), 1999-2006
• Decision Support Database: Total Female Population of Age 65 Years and Above in Millions (World), 1999-2006
• Decision Support Database: Number of Beds in Psychiatric Hospitals in ' 000 (World), 1999-2006
• Decision Support Database: Number of Physicians (World), 1999-2006